Chloride channel accessory 4 suppresses stem cell-like properties of colorectal cancer and enhances anti-PD-1 immunotherapy
Authors:
Open Access
- 1 May 2026
- journal article
- Published by KEAI Publishing in Genes & Diseases
- Vol. 13 (3) , 101859
Abstract
Reduced chloride channel accessory 4 (CLCA4) levels are linked to cancer development, while its role and mechanism in cancer stem cells (CSCs) remain unclear. In this study, we discovered that decreased CLCA4 expression was evident in CD133+CD44+ colorectal CSCs and chemoresistant colorectal cancer (CRC) cells. Increased expression of CLCA4 inhibited the expression of stemness genes, reduced tumorsphere formation, suppressed the self-renewal, migratory, and invasive capabilities of colorectal CSCs in vitro, and suppressed the tumorigenicity of colorectal CSCs in vivo. Mechanistically, CLCA4 interacted with vimentin, leading to FAK pathway inactivation and subsequent suppression of CSC expansion, while vimentin up-regulation attenuated the effects of CLCA4 down-regulation and established its role in CLCA4-mediated colorectal CSC self-renewal. Decreased CLCA4 expression was positively correlated with colorectal CSC markers and vimentin in clinical specimens. Increased CLCA4 expression promoted the infiltration of cytotoxic CD8+ T cells and enhanced the anti-PD-1 therapeutic efficacy. Our findings suggest that CLCA4 could impede colorectal CSC self-renewal by interacting with vimentin to suppress the FAK signaling pathway, potentially reducing tumor cell stemness and evading immune surveillance. The new findings on cellular and molecular mechanisms underpinning CRC development and progression could offer new perspectives for potential intervention and treatment of CRC.Keywords
Funding Information
- National Natural Science Foundation of China (81972780)
- Natural Science Foundation of Guangdong Province (2020A1515010051)
This publication has 35 references indexed in Scilit:
- Targeting cancer stem cells for reversing therapy resistance: mechanism, signaling, and prospective agentsSignal Transduction and Targeted Therapy, 2021
- CD44+CD24-/low sphere-forming cells of EBV-associated gastric carcinomas show immunosuppressive effects and induce Tregs partially through production of PGE2Experimental Cell Research, 2020
- Cancer cells stemness: A doorstep to targeted therapyBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- A prognostic eight‐gene expression signature for patients with breast cancer receiving adjuvant chemotherapyJournal of Cellular Biochemistry, 2019
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 studyThe Lancet Oncology, 2017
- Cancer incidence and mortality in China, 2013Cancer Letters, 2017
- Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growthNature Cell Biology, 2015
- Immunotherapy Exposes Cancer Stem Cell Resistance and a New Synthetic LethalityMolecular Therapy, 2013
- Identification and expansion of human colon-cancer-initiating cellsNature, 2006
- A human colon cancer cell capable of initiating tumour growth in immunodeficient miceNature, 2006